News | Endovascular Aortic Repair | February 18, 2022

Front Line Medical Technologies Expands Availability of its COBRA-OS

The FDA Cleared and Health Canada approved 4 French REBOA device saves valuable time by controlling bleeding in situations of traumatic injury and severe hemorrhage

Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.

COBRA-OS


February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.

Previously available in limited quantities, Front Line is now increasing production based on patient success rates and interest from hospitals looking for modern trauma technology solutions.

The COBRA-OS, which is approved by Health Canada and cleared by the FDA, is the first 4 French REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) device and the smallest on the market.  The device can provide full, intermittent, or partial occlusion depending on the patient’s need, and has a uniquely designed Safety Shoulder Reservoir incorporated into the device to help prevent aortic rupture during inflation.

In addition to trauma, the COBRA-OS has been recently used to treat a pregnant patient to help reduce the bleeding associated with placenta percreta, a condition with a high mortality for mother and child. It has even been used for non-bleeding situations to bring a patient back to life who had cardiac arrest outside the hospital and CPR for 30 minutes before arriving in the emergency department.

COBRA-OS Key Features

At Victoria Hospital in London, Ontario, Canada, vascular surgeon and COBRA-OS co-creator Dr. Adam Power has successfully utilized the device in traumatic bleeding cases to stabilize patients, providing critical time to get patients to the operating room for definitive care.

“The COBRA-OS is tiny but has a huge impact for patients. When a patient is bleeding to death in front of you, simple solutions are key and the COBRA-OS is the most straightforward REBOA device available,” said Power. “When the COBRA-OS is used appropriately, it can be one of the most powerful tools in your hemorrhage control toolbox.”

With the availability of the COBRA-OS device in U.S. and Canadian hospitals, Front Line is proud to offer a quicker and simpler hemorrhage control option to medical professionals across several subspecialties and is looking forward to the continued adoption of the COBRA-OS device in a wider range of in and out of hospital settings as the company continues to expand into new fields and works to save more lives.

For more information: https://frontlinemedtech.com


Related Content

News | Endovascular Aortic Repair

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

Home October 26, 2022
Home
News | Endovascular Aortic Repair

March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of ...

Home March 22, 2022
Home
News | Endovascular Aortic Repair

May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...

Home May 12, 2021
Home
News | Endovascular Aortic Repair

February 23, 2021 — Medtronic has voluntarily issued a global recall of unused Medtronic Valiant Navion thoracic stent ...

Home February 23, 2021
Home
News | Endovascular Aortic Repair

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting ...

Home January 31, 2020
Home
News | Endovascular Aortic Repair

January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA) ...

Home January 29, 2020
Home
News | Endovascular Aortic Repair

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

Home November 11, 2019
Home
News | Endovascular Aortic Repair

November 21, 2018 — New research in the December edition of the Journal of Vascular Surgery suggests significant ...

Home November 21, 2018
Home
News | Endovascular Aortic Repair

October 8, 2018 — Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a ...

Home October 08, 2018
Home
Feature | Endovascular Aortic Repair | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.

Here are several considerations for physicians when choosing endovascular stent grafts used to treat aortic aneurysms ...

Home February 05, 2018
Home
Subscribe Now